Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers (Q38247180)

1 September 2017

1 reference

title

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers (English)

1 reference

neuropsychiatric systemic lupus erythematosus

1 September 2017

0 references

0 references

author name string

Hélène Jeltsch-David

series ordinal

1

1 reference

1 September 2017

Sylviane Muller

series ordinal

2

1 reference

1 September 2017

language of work or name

English

0 references

publication date

9 September 2014

1 reference

1 September 2017

Nature Reviews Neurology

1 reference

1 September 2017

10

1 reference

1 September 2017

579-596

1 reference

1 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2014.148

1 September 2017

0 references

cites work

Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Genetic and hormonal factors in female-biased autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Environment and lupus-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Newer therapeutic approaches for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus: a review of the disease and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Sex differences and genomics in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoimmune diseases and reproductive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Psychiatric illness of systemic lupus erythematosus in childhood: spectrum of clinically important manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Trex1 prevents cell-intrinsic initiation of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Pathogenesis and treatment of CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Diagnosis and management of neuropsychiatric SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The history of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Standardization of antiphospholipid antibody assays. Where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Management of neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Distinct subtypes of myelitis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The neuropathology and pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neurolupus (1re partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cerebral manifestations in the antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Perceived illness stigma is associated with depression in female patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The ACR classification criteria for headache disorders in SLE fail to classify certain prevalent headache types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric features of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoantibodies in lupus: culprits or passive bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Structure and function of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The blood-brain barrier in neurodegenerative disease: a rhetorical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The blood-brain barrier in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Losing your nerves? Maybe it's the antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus and the brain: what mice are telling us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Immunoglobulin binding to brain in autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

C5a alters blood-brain barrier integrity in experimental lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoantibodies in neuropsychiatric lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Intrathecal antibodies and brain damage in autoimmune MRL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Platelet C4d is associated with acute ischemic stroke and stroke severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Immunity and acquired alterations in cognition and emotion: lessons from SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Brain-reactive antibodies and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Antiphospholipid antibodies and cerebral lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The significance of autoantibodies against β2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cognition and immunity; antibody impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus, the brain, and anti-NR2 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Immunity and behavior: antibodies alter emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

PolyADP-ribosylation is required for long-term memory formation in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Hippocampal atrophy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Hippocampal damage in mouse and human forms of systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cytokines and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The TWEAK-Fn14 system as a potential drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Chemokines in systemic lupus erythematosus involving the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Characteristics, treatments and outcome of psychosis in Thai SLE patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

PET/CT imaging in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cerebral and corpus callosum atrophy in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

White matter hyperintensities in mid-adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Diffusion tensor imaging in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neurolupus (2e partie). Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Epidemiology of Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

TREX1 gene variant in neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

31 March 2020

Neuropsychiatric lupus

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Acute psychosis in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Lupus headache may not exist: comment on the article by Hanly et Al

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Diagnostic criteria for systemic lupus erythematosus: has the time come?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric systemic lupus erythematosus reconsidered

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus and lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.148

Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report.

31 March 2020

1 reference

12 December 2020

Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data

1 reference

12 December 2020

Lupoid sclerosis with antiphospholipid and antimyelin antibodies

1 reference

12 December 2020

Neuropsychiatric lupus: clinical and imaging aspects.

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.

1 reference

12 December 2020

Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Lupus. The disease with a thousand faces

1 reference

12 December 2020

Neuropsychiatric lupus: classification criteria in neuroimaging studies

1 reference

12 December 2020

Brain pathology in systemic lupus erythematosus

1 reference

12 December 2020

Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin

1 reference

12 December 2020

Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus

1 reference

12 December 2020

10.1038/NRNEUROL.2014.148

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference